Department of Psychiatry, Chang Gung Memorial Hospital at Keelung. No.200, Lane 208, Ji-Jin 1st Rd., Anle District, Keelung City 204, Taiwan, ROC.
Psychiatr Danub. 2011 Mar;23(1):76-8.
Zolpidem is a non-benzodiazepine property which binds selectively to the ?1-GABAA receptors, and has been widely prescribed to patients suffering from insomnia. We report two cases of zolpidem dependence with withdrawal seizure in the Asian population. The first case is a 43-year-old woman who took zolpidem up to the dosage of 200 to 400 mg per night. The second case is a 35-year-old woman who even began to take zolpidem every 15 to 30 minutes to get euphoric and relaxed, and she gradually increased the dosage to 400 to 500mg per day. After abrupt discontinuation of zolpidem, both cases immediately developed anxiety, global insomnia, restlessness, and tonic seizure. The purpose of this case report is to suggest that clinicians should pay close attention to the potential of zolpidem tolerance, abuse and dependence. The possibility of withdrawal seizure cannot be excluded especially at high doses.
唑吡坦是一种非苯二氮䓬类药物,具有选择性结合?1-GABAA 受体的特性,已被广泛用于治疗失眠症患者。我们报告了两例亚洲人群中因唑吡坦依赖而出现戒断性癫痫发作的病例。第一例是一名 43 岁女性,每晚服用唑吡坦的剂量高达 200 至 400 毫克。第二例是一名 35 岁女性,甚至开始每 15 至 30 分钟服用一次唑吡坦以获得欣快和放松的感觉,并且她逐渐将剂量增加到每天 400 至 500 毫克。在突然停止使用唑吡坦后,这两例患者立即出现焦虑、全身性失眠、不安和强直发作。本病例报告的目的是建议临床医生密切关注唑吡坦耐受、滥用和依赖的潜在风险。特别是在高剂量下,不能排除戒断性癫痫发作的可能性。